Ocular Drug Delivery for Glaucoma Management
Current glaucoma management modalities are hindered by low patient compliance and adherence. This can be due to highly complex treatment strategies or poor patient understanding. Treatments focus on the management or reduction of intraocular pressure. This is most commonly done through the use of da...
Saved in:
Main Authors: | Barbara Wirostko (Author), Balamurali K. Ambati (Author), Bonnie Archer (Author), Russell Condie (Author), Randon Michael Burr (Author), Sarah A. Molokhia (Author), Nathan Gooch (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2012-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
by: Maneesha Peter, et al.
Published: (2021) -
Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma
by: Sandeep Divate Satyanarayana, et al.
Published: (2023) -
The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
by: Jayanetti V, et al.
Published: (2020) -
Topical Medication Therapy for Glaucoma and Ocular Hypertension
by: Tao Wang, et al.
Published: (2021) -
Inflammatory Molecules in Aqueous Humour and on Ocular Surface and Glaucoma Surgery Outcome
by: Barbara Cvenkel, et al.
Published: (2010)